SOLIGENIX, INC. Property, Plant and Equipment, Gross
SOLIGENIX, INC. (SNGX) had Property, Plant and Equipment, Gross of $157.93 thousand as of 2021-03-31, per its 10-Q filed 2021-05-18.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2021-05-18
- 2021-03-31: Property, Plant and Equipment, Gross $157.93K.
- 2020-12-31: Property, Plant and Equipment, Gross $154.77K; Property, Plant and Equipment, Gross as first filed $158.77K.
- 2019-12-31: Property, Plant and Equipment, Gross $135.04K.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2021-03-31 | $157.93K 10-Q · filed 2021-05-18 | |
| 2020-12-31 | $154.77K 10-Q · filed 2021-05-18 | $158.77K 10-K · filed 2021-03-30 |
| 2019-12-31 | $135.04K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |